logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert columns
    • Expert opinion
    • In the Zone
    • Infographics
    • Journal articles
    • Journal content
    • Spotlights
    • Supplements
    • Tech Digest

    Follow us on social media

  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensic
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates and regulations
      • Biopharmaceuticals
      • Collaborations and mergers
      • Data processing & interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large
      • Metabolites
      • Oligonucleotides
      • Small
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Videos
    • Interviews
    • Panel discussions
    • Webinars

    Follow us on social media

  • News
  • Learn
    • Awareness
    • Education zone
    • General interest
    • Professional development

    Follow us on social media

  • Partners
  • Register
WEBINAR: Measuring therapeutic oligonucleotides in biological matrices: a review of hybridization assay formats 3 days 12 hours 15 mins 59 secs Register Now!

Drug development

Drug development begins when a lead compound has been identified in a drug discovery process; it involves multiple stages that are required to bring a new pharmaceutical drug to market.

View more

The earliest stages of drug development involve preclinical studies to determine a candidate’s safety profile. However, the drug development process includes product characterization, formulation, delivery, packaging development, pharmacokinetics, pharmacodynamics, ADME, preclinical toxicology and finally clinical trials.

Clinical trials are made up of different phases, phases I – IV, with each phase recruiting more participants. Phase I looks to assess the safety of a drug or device. Phase II aims to test the efficacy and phase III studies involve randomized blind testing on large sample groups. Phase IV involves post marketing surveillance.

Bioanalytical studies and bioanalytical method development support most stages in the drug development process. This includes the appropriate characterization of molecules, assay development and optimal method development. Bioanalysis supports pre-clinical testing and clinical trials as well as quality assurance and quality control for the entire development process.

  • About
  • Advertising & Sponsorship
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
Contact
Contact Us
Office info

Bioanalysis Zone is powered by Newlands Press, part of Future Science Group

Bioanalysis Zone, Unitec House, 2 Albert Place, London, N3 1QB, UK

+44 (0)20 8371 6090

  • Future Science Group
  • More about PCSIG
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2023 Bioanalysis Zone